Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

Henry Schein (HSIC) has a Zacks Rank of #3 (Hold), but earns A scores for both Value and VGM, with a forward P/E of 15.4. The Zacks consensus fiscal 2026 EPS estimate is $5.36, unchanged over the period cited, while one analyst raised an estimate in the last 60 days; the company’s average earnings surprise is +8.4%. The article presents HSIC as a long-term value candidate, without reporting a new company event or share-price reaction.

Analysis

This is a valuation-screen feature, not a fresh fundamental catalyst. The key tension is that the attractive-looking forward multiple rests alongside a Zacks Hold rating and effectively flat consensus EPS; one upward analyst revision is too little breadth to establish improving fundamentals. The reported earnings-surprise history may support confidence, but without evidence that beats are recurring and converting to cash, it does not by itself justify multiple expansion.

Over the next 1–3 months, the trade depends more on estimate revisions and guidance than on the value label. Verify the basis for FY2026 EPS, recent organic growth, gross-margin trends, and cash conversion. For a distributor, mix, purchasing terms, and customer demand can offset volume growth; pressure there could make a low headline multiple a value trap. Patterson Companies (PDCO) is a relevant dental-distribution read-through, but relative positioning should be checked against current results rather than assumed.

Over 6–18 months, sustained earnings delivery could support a rerating; persistent flat estimates would leave the stock reliant on the value factor and expose it to de-rating if earnings weaken. The contrarian point: the article’s own data argue against treating HSIC as a high-conviction long now—the score is favorable, but estimate momentum is not. No compelling event-driven trade is established.

Key Decisions for Investors

• No immediate position change based on this article alone. Treat HSIC as a watchlist value candidate, not a confirmed earnings-revision inflection.
• Before initiating a long, check the next results and guidance for broad-based upward estimate revisions, organic sales growth, margin stability, and cash conversion; compare those trends with PDCO.
• Potential entry trigger: a sustained upward turn in consensus FY2026 EPS supported by company guidance and operating metrics. Falsify the long thesis if estimates remain flat or are cut, or if margins/cash conversion deteriorate.
• Avoid inferring cheapness from the cited forward P/E without validating the EPS forecast and comparing HSIC with peers on normalized earnings and growth.